AIA
BMY.RT

Arcadia Investment Advisors’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Arcadia Investment Advisors’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-717
Closed -$495 – 113
2020
Q4 		$495 Sell
717
-683
-49% -$1.46K ﹤0.01% 109
2020
Q3 		$3.15K Hold
1,400
– – ﹤0.01% 85
2020
Q2 		$5.01K Hold
1,400
– – ﹤0.01% 61
2020
Q1 		$5.32K Hold
1,400
– – ﹤0.01% 62
2019
Q4 		$4.21K Buy
+1,400
New +$3.64K ﹤0.01% 54

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Arcadia Investment Advisors's BMY.RT Position: Q1 2021 in Review

Arcadia Investment Advisors sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 717 shares — an estimated $495 sold.

Arcadia Investment Advisors first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $5.32K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Arcadia Investment Advisors reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Arcadia Investment Advisors sold 717 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $495.
  • Arcadia Investment Advisors first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Arcadia Investment Advisors's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $5.32K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Arcadia Investment Advisors's 13F filing for Q1 2021, filed 19 Dec 2024.